Marc Potash
Certify Global Inc.
9801 Washingtonian Boulevard
Suite 200
Gaithersburg , MD 20878
United States
marc.potash@certifyglobal.comIssued Mar 4, 2021Center for Devices and Radiological Health
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.
Violations1
Issue DateMar 4, 2021
Product TypeMedical Devices
StatusClosed
Closeout LetterDec 17, 2024
Letter Details
Firm
Certify Global Inc.
Location
Marc Potash
Certify Global Inc.
9801 Washingtonian Boulevard
Suite 200
Gaithersburg , MD 20878
United States
marc.potash@certifyglobal.com
FEI Number
N/A
Country
United States
Issue Date
March 04, 2021
Issuing Office
Center for Devices and Radiological Health
Product Type
Medical Devices
Status
Closed
Closeout Letter
December 17, 2024
Summary
Certify Global Inc. was cited for marketing two telethermographic devices—the SNAP XT PRO HID and InfinityX PRO—as medical devices for measuring human body temperature without FDA approval, clearance, or authorization. The products were found to be adulterated under section 501(f)(1)(B) of the Federal Food, Drug, and Cosmetic Act for lacking approved premarket approval (PMA) or investigational device exemption (IDE) applications, and misbranded under section 502(o) for failing to submit a 510(k) notification before introducing the devices into interstate commerce. The FDA determined that use of telethermographic devices for body temperature assessment presents potentially serious public health risks, including the possibility of incorrectly detecting normal temperatures in individuals who may be febrile.
Certify Global Inc. FDA Warning Letter, March 4, 2021